Drugs / JBPOS0101
last change Dec 2021 re-read 3 minutes ago

JBPOS0101

Small molecule

Developed for
infantile spasms
Investigated by
Bio-Pharm Solutions Co., Ltd.

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03976076 Apr 2020 → Dec 2021 infantile spasms Bio-Pharm Solutions Co., Ltd. Terminated No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as JBPOS0101 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03976076 ↗
Modality Small molecule — CHEMBL4594413 ↗